Roswell Park, MD Anderson, Memorial Sloan Kettering: The cancer centers that set the model for a nation

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Cancer History Project announces its first panel

Fifty years after Congress passed the National Cancer Act of 1971, establishing the effort to tackle cancer as a national priority, Cancer History Project co-editor Otis Brawley sits down with the directors of America’s first three comprehensive cancer centers to discuss the history, achievements, goals, and future directions of NCI-designated Comprehensive Cancer Centers. 

Join Otis Brawley in discussion with directors from the three centers that shaped the NCI Cancer Centers Program as model comprehensive centers:

Candace Johnson
President and CEO, Roswell Park Comprehensive Cancer Center
Peter WT Pisters 
President, MD Anderson Cancer Center
Craig B. Thompson
President and CEO, Memorial Sloan Kettering Cancer Center

Thursday, July 29, 5:30-7:30pm ET / 4:30-6:40pm CT

Free virtual event, register here


Recent contributions

Video: Ewing Sarcoma Patient Receives Bionic Bone
By The University of Kansas Cancer Center | June 10, 2021

People: Barton Kamen: A “Grand” Illusion
By Rutgers Cancer Institute of New Jersey | June 8, 2021

Institutions: Seattle Cancer Care Alliance Outpatient Clinic to Open – Jan. 19, 2001
By Seattle Cancer Care Alliance | June 7, 2021


This column features the latest posts to the Cancer History Project by our growing list of contributors

The Cancer History Project is a free, web-based, collaborative resource intended to mark the 50th anniversary of the National Cancer Act and designed to continue in perpetuity. The objective is to assemble a robust collection of historical documents and make them freely available. 

Access to the Cancer History Project is open to the public at CancerHistoryProject.com. You can also follow us on Twitter at @CancerHistProj.

Is your institution a contributor to the Cancer History Project? Eligible institutions include cancer centers, advocacy groups, professional societies, pharmaceutical companies, and key organizations in oncology. 

To apply to become a contributor, please contact admin@cancerhistoryproject.com.

Table of Contents

YOU MAY BE INTERESTED IN

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login